Clinical trial Recruiting at 1 site Observational Ages 60 and up

Understanding brain activity and postoperative delirium in older patients

Official title: Interventions for Postoperative Delirium: Biomarker-3

Run by University of Wisconsin, Madison · NCT03124303 · Data updated 2026-11-12

This study is trying to see how brain activity before surgery affects the chances of older patients developing confusion after major surgery.

Quick facts

Study typeObservational
Ages60 Years and up
SexAll
Enrollment468 (estimated)
SponsorUniversity of Wisconsin, Madison
Academic / other
Locations1 site (Madison, Wisconsin)
StatusRecruiting
StartedFebruary 13, 2017
Main results expectedDecember 2029
Study endsDecember 2029
Registry record updatedDecember 15, 2025
Trial IDNCT03124303 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 60 years and older who are scheduled for major surgery requiring at least a two-day hospital stay.

Probably not a fit

Patients with a documented history of dementia or those undergoing intracranial surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The IPOD-B3 study investigates how premorbid brain activity relates to the occurrence of postoperative delirium in patients aged 60 and older undergoing major surgery. This observational study utilizes high-density electroencephalogram (EEG), magnetic resonance imaging (MRI), blood specimen collection, and pupillometry to gather data. By expanding on previous research, it aims to identify biomarkers that could predict delirium risk. Participants will be monitored during their hospital stay and followed up to assess cognitive outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved strategies for preventing postoperative delirium in older adults.

How similar studies have gone: Other studies have explored similar approaches to understanding delirium, but this specific investigation into premorbid brain activity is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cohort 1: Age ≥65 years
* Cohort 2: Age ≥60 years
* Anticipated length of hospital stay of at least 2 days after surgery that occurs under general or neuraxial anesthesia
* Written Informed Consent for potential participation prior to surgery

Exclusion Criteria:

* Contraindication to EEG
* Unable or unwilling to attend the follow-up appointments
* Documented history of dementia
* Deemed incapable of providing consent by surgical team
* Residing in a nursing home
* Undergoing intracranial surgery
* Unable to complete neurocognitive testing due to language, vision or hearing impairment
* Unable to communicate with the research staff due to language barriers
* For optional MRI portion of the study: Contraindication to MRI (e.g., implanted devices not safe for MRI studies, claustrophobia, unable to lie flat or still)

Where it's running

  • University of Wisconsin-Madison
    Madison, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Robert Pearce, MD, PhD — University of Wisconsin, Madison
  • Study coordinator: David Kunkel, BS
  • Email: dkunkel@wisc.edu
  • Phone: 608-262-6469

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.